proteus infections

Summary

Summary: Infections with bacteria of the genus PROTEUS.

Top Publications

  1. ncbi Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients
    R Saito
    Department of Infection Control and Prevention, The University of Tokyo Hospital, Tokyo, Japan
    Clin Microbiol Infect 13:1204-6. 2007
  2. pmc Classification, identification, and clinical significance of Proteus, Providencia, and Morganella
    C M O'Hara
    Hospital Infections Program, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 13:534-46. 2000
  3. pmc Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases
    Andrea Endimiani
    Laboratorio di Microbiologia, Ospedale di Circolo e Università dell Insubria, Viale Borri 57, 21100 Varese, Italy
    Antimicrob Agents Chemother 49:2598-605. 2005
  4. ncbi A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli
    Beatriz Mirelis
    Servicio de Microbiologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
    Enferm Infecc Microbiol Clin 24:370-2. 2006
  5. pmc Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis
    S M Jacobsen
    Department of Biomedical Sciences, Dental School, University of Maryland Baltimore, Room 9209, 650 W Baltimore Street, Baltimore, MD 21201, USA
    Clin Microbiol Rev 21:26-59. 2008
  6. pmc Potential virulence factors of Proteus bacilli
    A Rozalski
    Institute of Microbiology and Immunology, University of Lodz, Poland
    Microbiol Mol Biol Rev 61:65-89. 1997
  7. ncbi [Proteus bacilli: features and virulence factors]
    Antoni Rozalski
    Zakład Immunobiologii Bakterii, Instytut Mikrobiologii i Immunologii Uniwersytetu Łódzkiego, Poland
    Postepy Hig Med Dosw (Online) 61:204-19. 2007
  8. pmc The Dienes phenomenon: competition and territoriality in Swarming Proteus mirabilis
    A E Budding
    VU Medical Centre, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands
    J Bacteriol 191:3892-900. 2009
  9. ncbi Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000)
    Baek Nam Kim
    Division of Infectious Diseases, Keimyung University Dongsan Medical Center, Daegu, Korea
    Scand J Infect Dis 35:98-103. 2003
  10. ncbi Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital
    Ja Young Kim
    Department of Clinical Pathology, College of Medicine, The Catholic University of Korea, Kangnam St Mary s Hospital, 505 Banpo Dong, Seocho Ku, Seoul 137 701, Korea
    J Antimicrob Chemother 54:1144-7. 2004

Detail Information

Publications181 found, 100 shown here

  1. ncbi Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients
    R Saito
    Department of Infection Control and Prevention, The University of Tokyo Hospital, Tokyo, Japan
    Clin Microbiol Infect 13:1204-6. 2007
    ..The majority of ciprofloxacin-resistant P. mirabilis isolates were multiresistant, and ciprofloxacin resistance was associated significantly with previous use of fluoroquinolones and production of extended-spectrum beta-lactamases...
  2. pmc Classification, identification, and clinical significance of Proteus, Providencia, and Morganella
    C M O'Hara
    Hospital Infections Program, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 13:534-46. 2000
    ..Many of these organisms are easily controlled, but the advent of newer and more powerful antimicrobial agents has led to some problems of which laboratorians need to be aware...
  3. pmc Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases
    Andrea Endimiani
    Laboratorio di Microbiologia, Ospedale di Circolo e Università dell Insubria, Viale Borri 57, 21100 Varese, Italy
    Antimicrob Agents Chemother 49:2598-605. 2005
    ..mirabilis isolates. Thus, recognition of ESBL-positive strains appears to be critical for the clinical management of patients with systemic P. mirabilis infections...
  4. ncbi A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli
    Beatriz Mirelis
    Servicio de Microbiologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
    Enferm Infecc Microbiol Clin 24:370-2. 2006
    ..The purpose of this study was to assess screening methods for the detection of these enzymes in clinical isolates of Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis...
  5. pmc Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis
    S M Jacobsen
    Department of Biomedical Sciences, Dental School, University of Maryland Baltimore, Room 9209, 650 W Baltimore Street, Baltimore, MD 21201, USA
    Clin Microbiol Rev 21:26-59. 2008
    ..Research focusing on the pathogenesis of CAUTIs will lead to a better understanding of the disease process and will subsequently lead to the development of new diagnosis, prevention, and treatment options...
  6. pmc Potential virulence factors of Proteus bacilli
    A Rozalski
    Institute of Microbiology and Immunology, University of Lodz, Poland
    Microbiol Mol Biol Rev 61:65-89. 1997
    ..All these features and factors are described and commented on in detail. The questions important for future investigation of these facultatively pathogenic microorganisms are also discussed...
  7. ncbi [Proteus bacilli: features and virulence factors]
    Antoni Rozalski
    Zakład Immunobiologii Bakterii, Instytut Mikrobiologii i Immunologii Uniwersytetu Łódzkiego, Poland
    Postepy Hig Med Dosw (Online) 61:204-19. 2007
    ..Below we focus on data concerning the molecular basis of the pathogenicity of Proteus bacilli...
  8. pmc The Dienes phenomenon: competition and territoriality in Swarming Proteus mirabilis
    A E Budding
    VU Medical Centre, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands
    J Bacteriol 191:3892-900. 2009
    ..Dienes line formation has implications for the physiology of swarming and social recognition in bacteria...
  9. ncbi Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000)
    Baek Nam Kim
    Division of Infectious Diseases, Keimyung University Dongsan Medical Center, Daegu, Korea
    Scand J Infect Dis 35:98-103. 2003
    ..Providencia bacteraemia was relatively uncommon and it can be associated with infections other than UTI...
  10. ncbi Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital
    Ja Young Kim
    Department of Clinical Pathology, College of Medicine, The Catholic University of Korea, Kangnam St Mary s Hospital, 505 Banpo Dong, Seocho Ku, Seoul 137 701, Korea
    J Antimicrob Chemother 54:1144-7. 2004
    ..To examine the molecular mechanisms involved in the beta-lactam resistance of multidrug-resistant Proteus mirabilis isolates that showed an unusual synergy between imipenem and ceftazidime in a Korean hospital...
  11. pmc Emerging extended-spectrum beta-lactamases in Proteus mirabilis
    Laura Pagani
    Dipartimento di Scienze Morfologiche, Eidologiche e Cliniche, Sezione di Microbiologia, Universita di Pavia, Italy
    J Clin Microbiol 40:1549-52. 2002
    ..Analysis of clonal diversity of the ESBL producers suggested different spreading patterns for the two ESBL determinants...
  12. ncbi [Proteus penneri]
    Rafael Canton
    Servicio de Microbiologia, Hospital Universitario Ramon y Cajal, Madrid, Espana
    Enferm Infecc Microbiol Clin 24:8-13. 2006
    ..This phenotype resembles the production of an extended spectrum beta-lactamase. Like other Proteus species, P. penneri is resistant to tetracyclines and should be considered resistant to nitrofurantoin...
  13. ncbi [Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins]
    Cynthia Rodriguez
    Cátedra de Análisis Clínicos I, Laboratorio de Bacteriologia, Hospital de Clinicas, Universidad de Buenos Aires, Argentina
    Enferm Infecc Microbiol Clin 23:122-6. 2005
    ..The aim of this study was to evaluate betalactam resistance within the genus Proteus and characterize the betalactamases responsible for this resistance...
  14. ncbi Prevalence of extended-spectrum beta-lactamases in Proteus mirabilis in a Taiwanese university hospital, 1999 to 2005: identification of a novel CTX-M enzyme (CTX-M-66)
    Jiunn Jong Wu
    Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan
    Diagn Microbiol Infect Dis 60:169-75. 2008
    ..mirabilis...
  15. ncbi Molecular diversity of Proteus mirabilis isolates producing extended-spectrum beta-lactamases in a French university hospital
    M Biendo
    Laboratoire de Bactériologie et Hygiène, CHU Nord, France
    Clin Microbiol Infect 11:395-401. 2005
    ..3%) and 12 (26.6%) isolates, respectively. These pulsotypes were considered to represent epidemic strains and spread in various wards of the hospital...
  16. pmc Noninvasive biophotonic imaging for monitoring of catheter-associated urinary tract infections and therapy in mice
    Jagath L Kadurugamuwa
    Xenogen Corporation, 860 Atlantic Avenue, Alameda, California 94501, USA
    Infect Immun 73:3878-87. 2005
    ....
  17. ncbi [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection]
    L Pape
    Abteilung für pädiatrische Nephrologie und Stoffwechselerkrankungen, Medizinische Hochschule Hannover
    Klin Padiatr 216:83-6. 2004
    ..We intended to evaluate data from northern Germany...
  18. pmc Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold
    Laurel S Burall
    Department of Microbiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Infect Immun 72:2922-38. 2004
    ....
  19. ncbi Ascending to a UTI vaccine?
    Sheilagh Clarkson
    Nat Rev Microbiol 2:90. 2004
  20. pmc Molecular epidemiology of Proteus mirabilis infections of the catheterized urinary tract
    N A Sabbuba
    Cardiff School of Biosciences, Cardiff University, Cardiff, United Kingdom
    J Clin Microbiol 41:4961-5. 2003
    ..mirabilis can persist in the urinary tract despite many changes of catheter, periods of noncatheterization, and antibiotic therapy...
  21. ncbi [Urinary tract infection in institutionalized elderly patients. Incidence of bacterial resistance and risk factors]
    V Faus Felipe
    Servicio de Farmacia, Centro Sociosanitario La Florida, Alicante
    Farm Hosp 27:298-303. 2003
    ....
  22. ncbi Swarming of Proteus mirabilis over ureteral stents: a comparative assessment
    James D Watterson
    Division of Urology, University of Western Ontario, London, Ontario, Canada
    J Endourol 17:523-7. 2003
    ....
  23. ncbi Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections
    Rafael Pellegrino
    Laboratorio de Microbiologia, Instituto de Investigaciones Biologicas Clemente Estable, Av Italia 3318, P O Box 11600, Montevideo, Uruguay
    FEMS Immunol Med Microbiol 36:103-10. 2003
    ..mirabilis experimental challenges. These results may contribute to the development of vaccines against P. mirabilis, an important cause of complicated UTI...
  24. ncbi Gudair (OJD) vaccine self-inoculation: a case for early debridement
    Graeme D Richardson
    School of Rural Health, University of New South Wales, Wagga Wagga, NSW
    Med J Aust 183:151-2. 2005
  25. ncbi Rheumatoid arthritis and proteus
    Alan Ebringer
    Clin Med 5:420-1. 2005
  26. ncbi Genotyping of urinary and fecal Proteus mirabilis isolates from individuals with long-term urinary catheters
    S Mathur
    Bristol Urological Institute, Southmead Hospital, Bristol, BS10 5NB, UK
    Eur J Clin Microbiol Infect Dis 24:643-4. 2005
  27. ncbi Evaluation of a modified double-disc synergy test for detection of extended spectrum beta-lactamases in AMPC beta-lactamase-producing proteus mirabilis
    M K R Khan
    Department of Microbiology, V P Chest Institute, University of Delhi, Delhi 110 007, India
    Indian J Med Microbiol 26:58-61. 2008
    ..The study demonstrated that MDDST is superior to DDST and as sensitive as NCCLS-PDCT. However, MDDST seems to have enhanced potential for the detection of ESBLs in AmpC beta-lactamase-producing P. mirabilis ...
  28. ncbi An iron-regulated outer-membrane protein of Proteus mirabilis is a haem receptor that plays an important role in urinary tract infection and in in vivo growth
    Analia Lima
    Laboratorio de Microbiologia, Instituto de Investigaciones Biologicas Clemente Estable, Av Italia 3318, CP 11600, Montevideo, Uruguay
    J Med Microbiol 56:1600-7. 2007
    ..mirabilis 64 kDa iron-regulated OMP is a haem receptor that has an important role for survival and multiplication of these bacteria in the mammalian host and in the development of urinary tract infection...
  29. ncbi The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection
    Melanie M Pearson
    Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109 0620, USA
    J Med Microbiol 56:1277-83. 2007
    ..The role of the P. mirabilis TTSS, if any, is yet to be determined...
  30. ncbi Molecular epidemiology of ESbetaL producing P. mirabilis strains from a long-term care and rehabilitation facility in Italy
    Roberta Migliavacca
    Dipartimento di Scienze Morfologiche Eidologiche e Cliniche, Sezione di Microbiologia, Universita di Pavia, Italia
    New Microbiol 30:362-6. 2007
    ..An effective strategy to curtail the spread of ESbetaLs mediated resistance in LTCRFs could be to activate sourveillance programs to monitor routinely the entry of resistant bacteria...
  31. ncbi Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases
    L M Aragón
    Servei de Microbiologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    J Antimicrob Chemother 61:1029-32. 2008
    ....
  32. ncbi Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression
    Ana Fernandez
    Servicio de Microbiología Unidad de Investigación, Complejo Hospitalario, Universitario Juan Canalejo, La Coruna, Spain
    J Antimicrob Chemother 59:841-7. 2007
    ..To characterize the extended-spectrum beta-lactamases (ESBLs) as well as their genetic environment in different isolates of Enterobacteriaceae from a patient with repeated urinary tract infections...
  33. ncbi Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis
    Ryoichi Saito
    Department of Infection Control and Prevention, The University of Tokyo Hospital, Tokyo, Japan
    J Antimicrob Chemother 58:673-7. 2006
    ..We conducted a study to determine the role played by amino acid mutations in DNA gyrase and topoisomerase IV, and the AcrAB efflux pump in resistance to fluoroquinolones in clinical isolates of Proteus mirabilis...
  34. ncbi Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report
    Vincenzo Savini
    Unità Operativa Complessa di Microbiologia e Virologia Clinica, Dipartimento di Medicina Trasfusionale, Ospedale Civile Spirito Santo, Pescara, Italy
    Int J Low Extrem Wounds 7:99-101. 2008
    ..This article focuses on diffusion and clinical effect of extended-spectrum beta-lactamases-producing Proteus mirabilis on treatment of gram negative lower extremity infections...
  35. ncbi Proteus mirabilis spondylodiscitis complicating a urinary tract infection
    Jeroen P P Smits
    Department of Internal Medicine, Groene Hart Ziekenhuis, Gouda, The Netherlands
    Scand J Infect Dis 38:575-6. 2006
    ..Haematogenous invasion may follow urosepsis. We report on a case of septic spondylodiscitis following urosepsis with Proteus mirabilis, a frequently isolated microorganism in urinary tract infections but rarely in spondylodiscitis...
  36. doi Purple like a glove
    Brandon Eilertson
    Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
    J Hosp Med 3:430. 2008
  37. ncbi [Proteus mirabilis community-acquired pneumonia]
    I Villamil Cajoto
    An Med Interna 23:146. 2006
  38. ncbi Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model
    Peter A Cadieux
    Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada
    J Urol 175:2331-5. 2006
    ..Using a rabbit model of UTI we examined the effects of triclosan impregnated stent segments on the growth and survival of Proteus mirabilis, a uropathogen commonly associated with device related UTI and encrustation...
  39. ncbi Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene
    S Vourli
    Department of Microbiology, National School of Public Health, Athens, Greece
    Clin Microbiol Infect 12:691-4. 2006
    ..This is the first description of the bla(VIM-1) metallo-beta-lactamase gene in P. mirabilis...
  40. ncbi Detection and mutation of a luxS-encoded autoinducer in Proteus mirabilis
    Rachel Schneider
    Center of Marine Biotechnology, University of Maryland Biotechnology Institute, 701 East Pratt Street, Baltimore, MD 21202, USA
    Microbiology 148:773-82. 2002
    ..While lacking AI-2 activity, a null mutation in luxS, however, did not affect swimming or swarming motility, swarmer cell differentiation, or virulence in a mouse model of ascending urinary tract infection...
  41. ncbi Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides
    Agnieszka Torzewska
    Department of Immunobiology of Bacteria, Institute of Microbiology and Immunology, University of Lodz, Poland
    J Med Microbiol 52:471-7. 2003
    ..This points to the increased importance of endotoxin in urinary tract infections...
  42. pmc Repression of bacterial motility by a novel fimbrial gene product
    X Li
    Department of Microbiology and Immunology, University of Maryland School of Medicine and Veterans Affairs Medical Center, Baltimore, MA 21201, USA
    EMBO J 20:4854-62. 2001
    ..mirabilis strain HI4320 is attenuated in the murine model. Our data also indicate that PapX encoded by a pap (pyelonephritis- associated pilus) operon of uropathogenic Escherichia coli is a functional homolog of MrpJ...
  43. pmc UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections
    Jonathan D Dattelbaum
    Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore 21201, USA
    Infect Immun 71:1026-30. 2003
    ..016), and kidneys (P < or = 0.001) 7 days after inoculation. Thus, UreR is required for basal urease activity in the absence of urea, for induction of urease by urea, and for virulence of P. mirabilis in the urinary tract...
  44. pmc Urinary tract infection in adolescent boys
    A J Khan
    Meharry Medical College, Brooklyn, New York, USA
    J Natl Med Assoc 88:25-6. 1996
    ..Forty-eight percent showed structural anomalies of the urinary tract. Recurrences were observed only in those having abnormalities of the urinary tract...
  45. ncbi Ascending urinary tract infections in rats induced by Staphylococcus saprophyticus and Proteus mirabilis
    E Hjelm
    Institute of Clinical Bacteriology, University of Uppsala, Sweden
    Acta Pathol Microbiol Immunol Scand B 95:347-50. 1987
    ..The antibody response to the different organisms was the same either the bacteria were instilled separately or in combination...
  46. ncbi [Urolithiasis in hemodialysis patients]
    Kikuo Nutahara
    Department of Urology, Kyorin University School of Medicine
    Nihon Rinsho 62:370-3. 2004
  47. pmc Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection
    Greta R Nielubowicz
    Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    Infect Immun 78:2823-33. 2010
    ..Since we demonstrated a role for ZnuC in zinc transport, we hypothesize that there is limited zinc present in the urinary tract and P. mirabilis must scavenge this ion to colonize and persist in the host...
  48. ncbi Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection
    A H Mutnick
    The JONES Group JMI Laboratories, North Liberty, Iowa 52317, USA
    J Chemother 14:253-8. 2002
    ..Imipenem also showed decreased susceptibility of greater than 7% compared to less than 1% for meropenem. Continued surveillance by the MYSTIC Program appears to be a prudent practice to focus effective empiric treatment regimens...
  49. ncbi Characterization and serological classification of a collection of Proteus penneri clinical strains
    Dominika Drzewiecka
    Department of General Microbiology, Institute of Microbiology and Immunology, University of Łódź, Łódź, Poland
    Arch Immunol Ther Exp (Warsz) 52:121-8. 2004
    ..The aim of this research was a serological characterization and classification of 57 Proteus penneri clinical strains, isolated from patients from different countries all over the world, into Proteus O serogroups...
  50. ncbi Skin and soft tissue infection: frequency of aerobic bacterial isolates and their antimicrobial susceptibility pattern
    Varsha Gupta
    J Assoc Physicians India 56:389-90. 2008
  51. ncbi Psoas abscess ten years after ipsilateral nephrectomy for pyonephrosis
    L Di Marco
    Azienda USL di Ferrara, Unità Operativa di Chirurgia Generale Ospedale Civile Mazzolani Vandini di Argenta
    G Chir 28:139-41. 2007
    ..The relation between psoas abscess and nephrectomy is unclear. To make diagnosis is important to consider this condition in differential diagnosis in presence of fever and flank tenderness in a nephrectomized patient...
  52. ncbi Management of chronic gangrenous mastitis in a 3-year-old cow using partial (quarter) mastectomy
    A M Phiri
    Department of Clinical Studies, School of Veterinary Medicine, University of Zambia, P O Box 32379, Lusaka, Zambia
    Trop Anim Health Prod 42:1057-61. 2010
    ..Partial mastectomy can be a safe and effective procedure for ruminants with udder disease in genetically or otherwise valuable cattle...
  53. ncbi Strategy to control catheter encrustation with citrated drinks: a randomized crossover study
    Azhar Khan
    BioMed Centre, Bristol Urological Institute, Southmead Hospital Bristol, Bristol, United Kingdom
    J Urol 183:1390-4. 2010
    ..If the safety margin between voiding pH and nucleation pH could be increased, it would increase the possibility of an alternative to controlling the activity of urease producing bacteria as a strategy to control catheter encrustation...
  54. ncbi Necrotizing otitis externa: 19 cases' report
    Ines Hariga
    ENT Department, Habib Thameur Hospital, Tunis, Tunisia
    Eur Arch Otorhinolaryngol 267:1193-8. 2010
    ..We had a 89.4% cure rate with only three cases of recurrence. We reviewed the data in the literature on necrotizing otitis externa and present the important diagnostic, imaging, and therapeutic aspects of the disease...
  55. pmc New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis
    Minghua Wang
    Institute of Antibiotics, Huashan Hospital, Fudan University, 12 M Wulumuqi Rd, Shanghai 200040, People s Republic of China
    Antimicrob Agents Chemother 53:1892-7. 2009
    ..qnrC could not be detected by PCR, however, in 2,020 strains of Enterobacteriaceae. A new quinolone resistance gene, qnrC, was thus characterized from plasmid pHS10 carried by a clinical isolate of P. mirabilis...
  56. ncbi [Prevalence of multidrug-resistant Proteus spp. strains in clinical specimens and their susceptibility to antibiotics]
    Adrian Reśliński
    Zakład Mikrobiologii Collegium Medicum im Ludwika Rydygiera w Bydgoszczy Uniwersytetu Mikołaja Kopernika w Toruniu
    Med Dosw Mikrobiol 57:175-84. 2005
    ..9% to co-trimoxazole, 77.7% to quinolones, 63.8% to tetracyclines, 38.5% to aminoglycosides, 19.3% to monobactams and 3.4% to carbapenems. Almost 25% multidrug-resistant Proteus sp. produced ESBL...
  57. ncbi Crystalline bacterial biofilm formation on urinary catheters by urease-producing urinary tract pathogens: a simple method of control
    Robert J Broomfield
    Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3TL, UK
    J Med Microbiol 58:1367-75. 2009
    ..0 in which catheter encrustation was inhibited. It is suggested that this dietary strategy will be an effective means of controlling catheter encrustation, whichever bacterial species is causing the problem...
  58. ncbi [Black nails caused by Proteus mirabilis]
    S A Qadripur
    Hautklinik, Abteilung Dermatologie und Venerologie, , von-Siebold-Strasse 3,
    Hautarzt 52:658-61. 2001
    ..Wet and dirty work encourages the colonisation of Proteus mirabilis between nail fold and nail plate...
  59. ncbi Vaccines for Proteus mirabilis in urinary tract infection
    Xin Li
    Department of Microbiology and Immunology, University of Maryland School of Medicine, 655 W Baltimore Street, Room 13 009, Baltimore, MD 21201, USA
    Int J Antimicrob Agents 19:461-5. 2002
    ..mirabilis, is a promising vaccine candidate. Successful vaccination would be expected both to prevent colonization by P. mirabilis and urolithiasis...
  60. ncbi [One-stage revision of knee endoprosthesis due to periprosthetic infection and Klippel-Trenaunay syndrome]
    H C Schmitz
    Orthopädische Chirurgie, ENDO Klinik Hamburg, Holstenstr 2, 22767, Hamburg, Deutschland
    Orthopade 40:624-6, 628-9. 2011
    ..Due to vascular anomalies with severe coagulation problems, soft tissue swelling and increased risk of infection, surgical treatment of such patients presents a special challenge...
  61. ncbi Species interactions in mixed-community crystalline biofilms on urinary catheters
    Sarah M Macleod
    Cardiff School of Biosciences, Cardiff University, Cardiff, UK
    J Med Microbiol 56:1549-57. 2007
    ..mirabilis and some of the other urinary tract organisms, the effects are temporary and whatever the pre-existing urinary microbiota, infection with P. mirabilis is thus likely to lead to catheter encrustation and blockage...
  62. ncbi [Enterobacter, Citrobacter, Proteus]
    Kazumichi Tamura
    Department of Bacteriology, National Institute of Infectious Diseases
    Nihon Rinsho 61:390-4. 2003
  63. ncbi Rheumatoid arthritis in smokers could be linked to Proteus urinary tract infections
    Taha Rashid
    School of Biomedical and Health Sciences, Kings College London, 150 Stamford Street, London SE1 9NN, UK
    Med Hypotheses 70:975-80. 2008
    ..Novel therapeutic and prophylactic measures are proposed, which might help to treat and/or prevent the disease process in individuals who are susceptible to develop RA...
  64. ncbi Regional outbreak of CTX-M-2 β-lactamase-producing Proteus mirabilis in Japan
    Ryuichi Nakano
    Kitasato University Graduate School of Medical Sciences, 1 15 1 Kitasato, Minami Ku, Sagamihara, Kanagawa 252 0374, Japan
    J Med Microbiol 61:1727-35. 2012
    ..These findings indicate the rapidly developing problem of treating the species to prevent dissemination of ESBL producers...
  65. ncbi Multifocal Proteus mirabilis osteomyelitis requiring bilateral amputation in an HIV-positive patient
    G Petsatodis
    1st Orthopaedic Department, Aristotle University of Thessalonika, G Papanikolaou Hospital, 57010 Exohi, Thessaloniki, Greece
    J Bone Joint Surg Br 89:249-51. 2007
    ..Multifocal Proteus mirabilis osteomyelitis can have an unpredictable clinical course with a severe outcome in HIV-positive patients...
  66. ncbi There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally
    Edward Stanford
    Department of Gynecology Urogynecology, Center for Advanced Pelvic Surgery, St Mary s Good Samaritan Hospital, Centralia, IL 62801, USA
    Int Urogynecol J Pelvic Floor Dysfunct 18:551-4. 2007
    ..These data suggest that the symptom flares of IC are not usually associated with recurrent UTI and, therefore, are likely due to a triggering of the other painful mechanisms involved in IC patients who are culture-negative...
  67. ncbi Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities
    Roberta Migliavacca
    Dipartimento di Scienze Morfologiche Eidologiche e Cliniche, Sezione di Microbiologia, Universita di Pavia, Pavia, Italy
    New Microbiol 30:295-8. 2007
    ..These results revealed multifocal spreading of a CMY-16 producing P. mirabilis clone in Northern Italy and emphasize the emergence of similar acquired resistance determinants in the LTCRFs setting...
  68. ncbi [Amyloidosis associated with chronic granulomatous disease in a patient with a renal transplant and recurrent urinary tract infections]
    R Peces
    Servicio de Nefrologia, Hospital Central de Asturias, Oviedo
    Nefrologia 22:486-91. 2002
    ....
  69. ncbi [A puzzle of the physician and the patient]
    Cathrine Midgaard
    Barnemedisinsk avdeling, Ulleval universitetssykehus, 0407 Oslo
    Tidsskr Nor Laegeforen 126:1756-7. 2006
  70. ncbi Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice
    Pablo Zunino
    Laboratorio de Microbiologia, Instituto de Investigaciones Biologicas Clemente Estable, Avda Italia 3318, CP11600, Montevideo, Uruguay
    Microbiology 149:3231-7. 2003
    ..mirabilis and that these fimbriae are widely distributed among P. mirabilis isolates from different origins since all strains tested expressed PmfA...
  71. ncbi [Wound care management of ulceration in a palliative care patient]
    Franz Reiner
    Palliativstation, Landeskrankenhaus Vöcklabruck, Osterreich
    Wien Med Wochenschr 156:302-4. 2006
    ..In our experience, photo documentation is helpful in decision-making during the treatment process. In addition, healing of larger defects seems to improve upon frequent and extensive liquid cleansing...
  72. ncbi Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis
    Caterina Mata
    Servei de Microbiologia, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Institut d Investigacions Biomèdiques Sant Pau, Barcelona, Spain
    J Antimicrob Chemother 66:2266-70. 2011
    ..To characterize the vectors involved in the dissemination of bla(CMY-2) genes in clinical isolates of Proteus mirabilis collected between 1999 and 2007...
  73. ncbi Images in emergency medicine. Infected urachal cyst
    Derek R Linklater
    Department of Pediatrics, Section of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA
    Ann Emerg Med 50:199, 210. 2007
  74. ncbi Integrin expression, enterocyte maturation, and bacterial internalization
    D J Hess
    Department of Surgery, University of Minnesota, 420 Delaware St SE, Minneapolis, MN 55455, USA
    J Surg Res 98:116-22. 2001
    ..Therefore, experiments were designed to study enterocyte integrin expression and differentiation, as well as enterocyte internalization of Salmonella typhimurium, Proteus mirabilis, and Escherichia coli...
  75. pmc Proteobactin and a yersiniabactin-related siderophore mediate iron acquisition in Proteus mirabilis
    Stephanie D Himpsl
    Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Mol Microbiol 78:138-57. 2010
    ..The fitness requirement for the yersiniabactin-related siderophore during UTI shows, for the first time, the importance of siderophore production in vivo for P. mirabilis...
  76. ncbi Outbreak caused by Proteus mirabilis isolates producing weakly expressed TEM-derived extended-spectrum β-lactamase in spinal cord injury patients with recurrent bacteriuria
    Lise Crémet
    Service de Bacteriologie Hygiene, CHU de Nantes, Nantes, France
    Scand J Infect Dis 43:957-61. 2011
    ..In such patients, ESBL detection in daily practice should be improved by systematic use of a synergy test in strains of P. mirabilis resistant to penicillins...
  77. ncbi High prevalence and molecular characterization of extended-spectrum β-lactamase-producing Proteus mirabilis strains in southern Croatia
    Marija Tonkic
    Department of Clinical Microbiology, University Hospital Split, Spinciceva 1, 21000 Split, Croatia
    J Med Microbiol 59:1185-90. 2010
    ..Increased monitoring and screening for ESBL production in this species at our hospital is mandatory...
  78. ncbi Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures
    W Kaca
    Department of Microbiology, Institute of Biology, Jan Kochanowski University, Kielce, Poland
    Biochemistry (Mosc) 76:851-61. 2011
    ..mirabilis UTI stains were identified. The diversity of serological reactions of LPSs is useful for serotyping of P. mirabilis clinical isolates. A possible role of the acidic components of O-antigens in UTI is discussed...
  79. ncbi Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections
    R Wasfi
    Department of Microbiology, Faculty of Pharmacy, University for Modern Sciences and Arts, Giza, Egypt
    Indian J Med Microbiol 30:76-80. 2012
    ..The aim of the present study was to evaluate the ability of the bacteria, isolated from urinary tract infections (UTIs) and wound infections, to form biofilm and correlate the role of biofilm with their antimicrobial resistance...
  80. ncbi Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections
    Veronika Hola
    Faculty of Medicine, Institute for Microbiology, Masaryk University and St Anna Teaching Hospital, Brno, Czech Republic
    FEMS Immunol Med Microbiol 65:343-9. 2012
    ..The virulence factors (twitching motility, swimming motility, swarming over various types of catheters and biofilm formation) were also more intensively expressed...
  81. ncbi Synthesis of monodispersed silver nanoparticles using Hibiscus cannabinus leaf extract and its antimicrobial activity
    M R Bindhu
    Department of Physics, Mother Teresa Women s University, Kodaikanal 624 101, Tamil Nadu, India
    Spectrochim Acta A Mol Biomol Spectrosc 101:184-90. 2013
    ..cannabinus leaf extract has been used as reducing agent. The prepared silver nanoparticle shows good antimicrobial activity against Escherichia coli, Proteus mirabilis and Shigella flexneri...
  82. pmc Cutaneo-pericardial fistula after transapical aortic valve implantation
    Michael Scheid
    Department of Cardiovascular Surgery, University Hospital Schleswig Holstein, Kiel, Germany
    Interact Cardiovasc Thorac Surg 16:558-9. 2013
    ..We report here the case of an 86-year old patient with a cutaneo-pericardial fistula after a transapical TAVI procedure...
  83. ncbi Complicated coexisting pyogenic and tuberculous otitis media affecting the temporozygomatic, infratemporal, and parotid areas: report of a rare entity
    Tripti Brar
    Department of ENT, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India
    Ear Nose Throat J 92:E10-2. 2013
    ..The patient was placed on antituberculosis drug therapy. Although her facial nerve palsy and hearing loss persisted, she otherwise responded well and did not require surgery...
  84. ncbi Proteus Takayasu's arteritis with unusual intracranial granulomatosis as initial manifestation
    Yu qiang Chen
    Department of Nephrology and Rheumatology, Sixth People s Hospital Shanghai, Jiao Tong University, 600 Yishan Road, 200233 Shanghai, China
    Rheumatol Int 32:2185-8. 2012
    ....
  85. ncbi [Clinical and molecular characterization of ESBL-producing enterobacteria isolated from bacteremia in a university hospital]
    Patricia García C
    Departamento de Laboratorios Cínicos, Pontificia Universidad Catolica de Chile, Santiago, Chile
    Rev Chilena Infectol 28:563-71. 2011
    ..Extended-spectrum-β-lactamases (ESBL) are plasmid-encoded enzymes that confer resistance to multiple antimicrobials. ESBL-producing enterobacteria that cause bacteremia limit therapeutic options and increase mortality...
  86. ncbi Effects of Taishan Pinus massoniana pollen polysaccharide on the subunit vaccine of Proteus mirabilis in birds
    Guolin Cui
    College of Animal Science and Technology, Shandong Agricultural University, Taian, Shandong 271018, PR China
    Int J Biol Macromol 56:94-8. 2013
    ..mirabilis; induced stronger humoral, cellular and mucosal immunity as compared with WO and PP; and should be developed as a vaccine adjuvant...
  87. pmc An unusual case of a ureteric hernia into the sciatic foramen causing urinary sepsis: successfully treated laparoscopically
    C Witney-Smith
    Department of Urology, Royal Free Hospital, London, UK
    Ann R Coll Surg Engl 89:W10-2. 2007
    ..The presentation was that of a 59-year-old woman with urinary tract sepsis associated with an acute deterioration of renal function. The hernia was successfully repaired laparoscopically...
  88. doi Crossed fused renal ectopia with calculi
    Bimal C Ghosh
    SUNY Downstate New York Harbor Healthcare System, Brooklyn, NY, USA
    J Am Coll Surg 206:753. 2008
  89. ncbi Preventing catheter-related urinary tract infection: focus on Proteus mirabilis
    Linda Nazarko
    Ealing NHS Trust
    Br J Community Nurs 16:528, 530-3. 2011
    ..However, it is important that staff are able to recognise the features of a Proteus infection. Proteus infections, if unrecognised, can become established and cause major health problems...
  90. pmc Serum immunoglobulin response and protection from homologous challenge by Proteus mirabilis in a mouse model of ascending urinary tract infection
    D E Johnson
    Research Service, VA Medical Center, Baltimore, Maryland 21201, USA
    Infect Immun 67:6683-7. 1999
    ..09), although only a few mice developed significant serum IgA levels. We conclude that prior infection with P. mirabilis does not protect significantly against homologous challenge...
  91. pmc Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection
    H L Mobley
    Department of Medicine, University of Maryland School of Medicine, Baltimore 21201, USA
    Infect Immun 64:5332-40. 1996
    ..mirabilis to colonize the urinary tract and cause acute pyelonephritis in an experimental model of ascending urinary tract infection...
  92. ncbi The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection
    Sandra M Jacobsen
    Department of Microbiology and Immunology, School of Medicine, University of Maryland Baltimore, Baltimore, MD, USA
    FEMS Immunol Med Microbiol 52:180-93. 2008
    ..mirabilis that is not required for in vitro growth. Thus, the Pst transporter has satisfied molecular Koch's postulates as a virulence factor in the pathogenesis of urinary tract infection caused by P. mirabilis...
  93. ncbi Microbial keratitis in a case of lamellar ichthyosis
    Sunita Chaurasia
    L V Prasad Eye Institute, Hyderabad, Andhra Pradesh, India
    Int Ophthalmol 28:367-8. 2008
    ..He was treated with topical ciprofloxacin and fortified cefazolin eyedrops. Microbial keratitis in patients with lamellar ichthyosis has a poor prognosis...
  94. ncbi Rheumatoid arthritis is caused by Proteus: the molecular mimicry theory and Karl Popper
    Alan Ebringer
    Analytical Sciences Group, King s College, London, England
    Front Biosci (Elite Ed) 1:577-86. 2009
    ..Anti-Proteus therapy should be assessed in the management of this disease separately or in conjunction with existing modalities of therapy...
  95. ncbi [Proteus mirabilis isolated from urine, resistance to antibiotics and biofilm formation]
    Lenka Cernohorská
    Microbiological Department, Masaryk University, St Anne s University Hospital Brno, Czech Republic
    Klin Mikrobiol Infekc Lek 17:81-5. 2011
    ..In the rather rare urinary pathogen Proteus mirabilis resistance to antibiotics and ability to form biofilm were studied...
  96. ncbi Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection
    Vijay Kumar
    Department of Nuclear Medicine and PET, Westmead Hospital, Westmead, Syndney, Australia
    Nucl Med Biol 38:393-8. 2011
    ..The present project explored whether (68)Ga-apo-transferrin ((68)Ga-TF), when prepared in vitro, is a useful agent for positron emission tomography (PET) imaging of bacterial infection...
  97. ncbi Asymptomatic bacteriuria during pregnancy
    Eyal Sheiner
    Faculty of Health Sciences, The Department of Obstetrics and Gynecology, Soroka University Medical Center, Be er Sheva, Israel
    J Matern Fetal Neonatal Med 22:423-7. 2009
    ..Our study was also designed to characterize common bacteria and risk factors associated with asymptomatic bacteriuria during pregnancy...
  98. ncbi [Epidemiology of ESBL-positive Enterobacteriaceae in Mantova hospital (Italy)]
    Gianni Gattuso
    Unita Operativa Malattie Infettive, Azienda Ospedaliera Carlo Poma, Mantova, Italy
    Infez Med 17:164-8. 2009
    ..The study enabled the change in the relative epidemiological data to be detected, and showed that such bacteria can be found almost throughout the hospital...
  99. ncbi Structural and serological studies of the O-polysaccharide of strains from a newly created Proteus O78 serogroup prevalent in Polish patients
    Dominika Drzewiecka
    Department of General Microbiology, University of Lodz, Lodz, Poland
    FEMS Immunol Med Microbiol 58:269-76. 2010
    ..Based on these data, we propose to classify the strains studied as a new serogroup in the genus Proteus named O78...
  100. ncbi Effects of the administration of cholera toxin as a mucosal adjuvant on the immune and protective response induced by Proteus mirabilis MrpA fimbrial protein in the urinary tract
    Paola Scavone
    Department of Microbiology, Institute of Biological Investigations Clemente Estable, UDELAR, Montevideo, Uruguay
    Microbiol Immunol 53:233-40. 2009
    ..Further studies are necessary to understand immune modulation in the urinary tract...
  101. pmc Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli
    M Chelsea Lane
    Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, 48109 0620, USA
    J Bacteriol 191:1382-92. 2009
    ..These findings provide evidence to support a mechanism for persistence of fimbriate bacteria under oxygen limitation, which is relevant to disease progression within the oxygen-restricted urinary tract...

Research Grants3

  1. Synchrotron imaging of crystalline biofilms in urinary catheters
    Aaron I Packman; Fiscal Year: 2010
    ..PUBLIC HEALTH RELEVANCE: Catheter blockage from Proteus infections still represents a major, ongoing, and serious problem for patients and for long-term care facilities...
  2. Development of a Urea Biosensor Using the UreR Protein
    HARRY MOBLEY; Fiscal Year: 2004
    ..abstract_text> ..
  3. UREASE AND GENE EXPRESSION OF HELICOBACTER PYLORI
    HARRY MOBLEY; Fiscal Year: 2008
    ..The long-term goals of the study are to understand the mechanism by which H. pylori can colonize the gastric mucosa and to identity more effective targets for therapeutic intervention. [unreadable] [unreadable]..